Key Drivers
- Strong liquidity
- Heavy cash burn
- Rising dilution
AIAI Summary
TSHA has shifted from a cash-runway story to a binary catalyst trade: its $279M cash cushion can bridge the gap, but near-term upside now depends almost entirely on whether TSHA-102 produces a credible REVEAL readout before ongoing burn and dilution pressure per-share value.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong liquidity
- •Heavy cash burn
- •Rising dilution
TSHA has a strong cash position and near-term solvency, but persistent losses, heavy cash burn, and rising dilution make the stock risky despite ample liquidity.
Price Behavior
Key Price Behavior Insights:
- •Fading momentum
- •Broken support
- •$6.00 hold
TSHA rallied through last month but the post-May 6 pullback back below $6.20–$6.30 shows fading momentum and leaves $6.00 as the key level to hold for the bullish case to stay intact.
Breakout lost traction after
Sentiment & News
Key News Insights:
- •TSHA-102 progress
- •Q1 disclosure
- •Hiring retention
Taysha's latest updates highlight encouraging TSHA-102 preclinical progress alongside routine Q1 reporting and employee equity grants, reinforcing steady pipeline execution and normal corporate cadence.
The news is modestly supportive as it signals continued scientific advancement while maintaining operational transparency
Similar Companies in Healthcare
Other companies in the same sector with AI ratings